tramadol plus paracetamol

Phase 1Small molecule

ZZagazig University

tramadol plus paracetamol is one of 2 small molecule programs targeting Enhanced Recovery. It is currently in Phase 1.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Enhanced RecoveryEnrolling by invitation

Enhanced RecoveryPhase 1

Enrolling by invitation

Competition

Competitive Landscape

4 competitors in Enhanced Recovery

#DrugCompanyPhaseTrials

Duragesic

CCephalon

Phase 1

1 2

tramadol plus paracetamol

ZZagazig University

Phase 1

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Enhanced Recovery1 trial

Paracetamol Plus Tramadol Versus Fentanyl As Preemptive Analgesia For Enhanced Recovery After Day Case Surgeries

Enrolling by invitation·ZZagazig University·Phase 1·NCT06561672·102 enrolled

Post Operative Pain1 trial

Paracetamol Plus Tramadol Versus Fentanyl as Pre-emptive Analgesia for Enhanced Recovery After Day-Case Surgeries: A Randomised Controlled Trial

Completed·ZZagazig University·Approved·NCT05990686·102 enrolled

Sources

References

[1]
ClinicalTrials.gov — 2 trial records for tramadol plus paracetamol. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — tramadol plus paracetamol compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for tramadol plus paracetamol. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Zagazig University company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 1[1]
Company: ZZagazig University

tramadol plus paracetamol

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Enhanced Recovery1 trial

Post Operative Pain1 trial

References

Drug Info

Quick Facts

Related News